Document is current

This article is maintained by: Elsevier

Article Title: Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2025.502201

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2024.502201

Content Type: article

Copyright: © 2024 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.